相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activating somatic and germline TERT promoter variants in myeloid malignancies
Valeria Nofrini et al.
LEUKEMIA (2021)
JASPAR 2020: update of the open-access database of transcription factor binding profiles
Oriol Fornes et al.
NUCLEIC ACIDS RESEARCH (2020)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
Federica Panebianco et al.
CANCER MEDICINE (2019)
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
cIMPACT-NOW update 3: recommended diagnostic criteria for Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV
Daniel J. Brat et al.
ACTA NEUROPATHOLOGICA (2018)
Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma
Jessica Tome-Garcia et al.
NATURE COMMUNICATIONS (2018)
Study of hTERT and Histone 3 Mutations in Medulloblastoma
Marta Viana-Pereira et al.
PATHOBIOLOGY (2017)
TERT promoter mutations in telomere biology
Barbara Heidenreich et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas
Yujin Lee et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT
Melike Pekmezci et al.
ACTA NEUROPATHOLOGICA (2017)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
TERT Promoter Mutations and Risk of Recurrence in Meningioma
Felix Sahm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations
Matthew M. Makowski et al.
PROTEOMICS (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
Zhen-Yu Zhang et al.
ONCOTARGET (2015)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
Yves Allory et al.
EUROPEAN UROLOGY (2014)
Kruppel-like factors in cancer progression: three fingers on the steering wheel
Ridha Limame et al.
ONCOTARGET (2014)
TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
分享论文
